Human immunodeficiency virus controllers: mechanisms of durable virus control in the absence of antiretroviral therapy.
about
CCL3L1-CCR5 Genotype Improves the Assessment of AIDS Risk in HIV-1-Infected IndividualsModeling the within-host dynamics of HIV infectionGenetic engineering of T cells for adoptive immunotherapyRedefining the viral reservoirs that prevent HIV-1 eradicationFoxo3a: an integrator of immune dysfunction during HIV infectionA global approach to HIV-1 vaccine developmentNatural SIV hosts: showing AIDS the doorSimian Immunodeficiency Virus Infection of Chimpanzees (Pan troglodytes) Shares Features of Both Pathogenic and Non-pathogenic Lentiviral InfectionsKinetics of myeloid dendritic cell trafficking and activation: impact on progressive, nonprogressive and controlled SIV infectionsSang Froid in a time of trouble: is a vaccine against HIV possible?CD4 dynamics over a 15 year-period among HIV controllers enrolled in the ANRS French observatoryPsoriasis patients are enriched for genetic variants that protect against HIV-1 diseaseIdentification of a cluster of HIV-1 controllers infected with low replicating virusesProfound depletion of HIV-1 transcription in patients initiating antiretroviral therapy during acute infectionThe major genetic determinants of HIV-1 control affect HLA class I peptide presentation.HIV-1 Genetic Variability and Clinical ImplicationsIncreased Levels of Macrophage Inflammatory Proteins Result in Resistance to R5-Tropic HIV-1 in a Subset of Elite Controllers.The impact of host genetic variation on infection with HIV-1.HIV-1 vaccine clinical trials: the Brazilian experience.Evolutionary dynamics of HIV at multiple spatial and temporal scales.Complete viral RNA genome sequencing of ultra-low copy samples by sequence-independent amplificationHIV-1 Vaccine Trials: Evolving Concepts and DesignsSoluble factors from T cells inhibiting X4 strains of HIV are a mixture of β chemokines and RNases.The HIV-1 pandemic: does the selective sweep in chimpanzees mirror humankind's future?The intracellular detection of MIP-1beta enhances the capacity to detect IFN-gamma mediated HIV-1-specific CD8 T-cell responses in a flow cytometric setting providing a sensitive alternative to the ELISPOT.Regulatory B cells inhibit cytotoxic T lymphocyte (CTL) activity and elimination of infected CD4 T cells after in vitro reactivation of HIV latent reservoirsCD8+ T cells from SIV elite controller macaques recognize Mamu-B*08-bound epitopes and select for widespread viral variation.HIV-1 disease-influencing effects associated with ZNRD1, HCP5 and HLA-C alleles are attributable mainly to either HLA-A10 or HLA-B*57 allelesRole of CCL3L1-CCR5 genotypes in the epidemic spread of HIV-1 and evaluation of vaccine efficacy.A novel method for producing target cells and assessing cytotoxic T lymphocyte activity in outbred hostsElite suppressor-derived HIV-1 envelope glycoproteins exhibit reduced entry efficiency and kineticsTransient nature of long-term nonprogression and broad virus-specific proliferative T-cell responses with sustained thymic output in HIV-1 controllersTwo MHC class I molecules associated with elite control of immunodeficiency virus replication, Mamu-B*08 and HLA-B*2705, bind peptides with sequence similarity.HIV controller CD4+ T cells respond to minimal amounts of Gag antigen due to high TCR avidity.Increased alpha-defensins 1-3 production by dendritic cells in HIV-infected individuals is associated with slower disease progressionElevation of intact and proteolytic fragments of acute phase proteins constitutes the earliest systemic antiviral response in HIV-1 infectionPerforin expression directly ex vivo by HIV-specific CD8 T-cells is a correlate of HIV elite control.Induction of Potent and Long-Lived Antibody and Cellular Immune Responses in the Genitorectal Mucosa Could be the Critical Determinant of HIV Vaccine Efficacy.The antiviral factor APOBEC3G improves CTL recognition of cultured HIV-infected T cells.Highly divergent patterns of genetic diversity and evolution in proviral quasispecies from HIV controllers.
P2860
Q19028101-B8B267E2-E6CC-483D-8EB2-6F99D3FC59B4Q21245370-BAB585C6-261B-4933-8CF2-D4661E0BA609Q24642718-376EEDFE-A4DB-424B-B4F9-D5759E762D58Q26827255-055B12AA-34C6-4092-953E-54E8D2FE1BFBQ26829456-B5AF386E-CFD1-4C0F-AC39-BD18F5AE48ADQ27024614-0DCDCFF0-0A7F-4685-AF21-1F701E7230B0Q27026135-80CE18E6-E64B-40C6-B7E2-B8F8B62AE980Q27317328-C2A451E3-55DD-49EE-85D3-90ABDA46202BQ27333255-AD86DE0F-9139-4841-B630-FA2F3E71B555Q27487961-D4221FD0-371F-447A-AD57-179D4452DC8FQ28477861-3A8A7742-8352-4379-BA34-88919FD127D1Q28483308-E6D4CF41-9C80-4E35-A545-B365057CCED4Q28534737-0F12B5B0-FA27-422C-BF70-2EABA2F9B597Q28748901-8127FF42-6C4D-4E7B-B06B-9D96404AF5D1Q29417018-9222416D-3FC6-44FA-ADFA-094573E4EFB4Q30352010-B446E4D4-14C9-4B28-B03B-83468B31764AQ30372415-7E0B5E72-2475-45B9-98C8-3F0F08ABD889Q30374810-1B2F5AB4-F6DE-4749-93F1-14373C7E273FQ30379462-5D0ECC45-2947-4404-9C55-DC0FB77AD3F4Q30416280-67B07DBF-D09D-4317-B28E-3BE377830C1BQ30421085-FAB0E0F3-DDDE-4FC3-B91C-1CF9D4B149F0Q30425520-17A44E8C-0946-45C1-8AE0-A33D96D38287Q30427403-D9039729-6F8A-4F41-A9D2-CC7631B74B62Q30431054-F2662EE7-D640-4617-9D0B-BB1E800CEAB1Q30484153-5E47B799-8C65-425D-AB85-93EFE3F58B09Q31158755-67A3088E-BD28-4964-84D3-364F9F3EC9CAQ33305428-59861CA1-C9C5-4B0B-B950-F717D00E8C66Q33382373-F38EB104-5E3A-427B-ACA6-E365D08FC171Q33383193-F9B67EC5-A5E9-4C35-B363-C1874C508E2EQ33417884-7F6D6E1E-2625-4C74-A592-D24D985B2F57Q33429049-000C0BB5-0C8A-4B0B-ABB8-BCDA327FF091Q33443913-C3C458A0-196F-4F6E-9FA0-4EA4D33AA339Q33459720-DE9A99D1-1F81-436D-B698-00A2B79DA7DCQ33535905-D93439FC-8755-41BE-B315-D85D59F3D72BQ33535953-517DBABF-25E0-414B-B0CD-1C0B70B610D4Q33576664-51415E1B-BA8A-4EFA-89E2-513530D3E916Q33594461-907D8129-B470-4D06-A523-5EE431AA6ABAQ33611645-6C7DED15-210B-4DE6-9873-C7F02CC9E14BQ33615181-476AB381-EEB6-4383-8E26-868DFE7C618CQ33630471-1B8D7747-964F-4E9D-8F9A-83C586C0D64D
P2860
Human immunodeficiency virus controllers: mechanisms of durable virus control in the absence of antiretroviral therapy.
description
2007 nî lūn-bûn
@nan
2007年の論文
@ja
2007年論文
@yue
2007年論文
@zh-hant
2007年論文
@zh-hk
2007年論文
@zh-mo
2007年論文
@zh-tw
2007年论文
@wuu
2007年论文
@zh
2007年论文
@zh-cn
name
Human immunodeficiency virus c ...... nce of antiretroviral therapy.
@en
type
label
Human immunodeficiency virus c ...... nce of antiretroviral therapy.
@en
prefLabel
Human immunodeficiency virus c ...... nce of antiretroviral therapy.
@en
P1433
P1476
Human immunodeficiency virus c ...... nce of antiretroviral therapy.
@en
P304
P356
10.1016/J.IMMUNI.2007.08.010
P407
P577
2007-09-01T00:00:00Z